To understand the mechanism of in utero exposure to BPA-associated tumor promotion in MMTV-erbB2 mice, we examined signaling in the ER and EGFR/erbB2 pathways in premalignant mammary tissues (PND 70) from mice with different in utero treatments. The gene discussed is ERBB2; the disease is neoplasm.